Table 4 Multivariable logistic regression analysis regarding risk factors for anxiety symptoms (HADS anxiety score) (n = 1,234)

Age at cancer diagnosis

 ≤ 39

1 (ref)

40–49

0.77

(0.48–1.23)

50–59

0.71

(0.44–1.14)

 ≥ 60

0.27

(0.15–0.49)

Time from cancer diagnosis, years

0–4

1 (ref)

5–9

0.75

(0.54–1.04)

10-

0.62

(0.42–0.90)

Sex

Male

1(ref)

Female

1.20

(0.78–1.86)

Cancer stage

Early (0, I)

1(ref)

Advanced (II, III, IV)

1.27

(0.92–1.76)

Cancer site

Intestinal

1(ref)

Gastric

1.12

(0.64–1.97)

Breast

0.94

(0.50–1.76)

Female genital

0.58

(0.30–1.13)

Male genital

1.33

(0.69–2.59)

Lung

1.50

(0.71–3.16)

Urinary

1.61

(0.90–2.90)

Hematological

0.50

(0.22–1.13)

Head and neck

0.98

(0.52–1.88)

Other

2.19

(1.19–4.03)

Surgery

No

1(ref)

Yes

1.00

(0.67–1.49)

Chemotherapy

No

1(ref)

Yes

1.56

(1.10–2.20)

Radiotherapy

No

1(ref)

Yes

1.03

(0.70–1.51)